Undue regulatory control on phenobarbital—an important yet overlooked reason for the epilepsy treatment gap

Simple item page
dc.contributor.authorBhalla, Devender
dc.contributor.authorAziz, Hasan
dc.contributor.authorBergen, Donna
dc.contributor.authorBirbeck, Gretchen L.
dc.contributor.authorCarpio, Arturo
dc.contributor.authorCavalheiro, Esper
dc.contributor.authorChivorakoun, Phetvongsinh
dc.contributor.authorHelen Cross, J.
dc.contributor.authorHouinato, Dismand
dc.contributor.authorNewton, Charles R.
dc.contributor.authorOdermatt, Peter
dc.contributor.authorRavat, Sangeeta
dc.date.accessioned2026-06-02T16:06:57Z
dc.date.available2026-06-02T16:06:57Z
dc.date.issued2015
dc.identifier.doi10.1111/epi.12929
dc.identifier.otherBECDB-2381
dc.identifier.urihttps://dspace.uac.bj/handle/123456789/2419
dc.language.isofr
dc.relation.ispartofEpilepsia
dc.subjectUndue regulatory control
dc.subjectphenobarbital
dc.subjectimportant
dc.subjectoverlooked reason
dc.subjectepilepsy
dc.subjecttreatment gap
dc.titleUndue regulatory control on phenobarbital—an important yet overlooked reason for the epilepsy treatment gap
dc.typeArticle

Files

Collections

Articles